MedPage Today on MSN
One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk
Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...
OT dives into a key topic in the education programme at 100% Optical 2026. This week: optometrist Mohamed Kasmani, and Joe Scott, from Mainline Instruments, on confocal ultra-widefield imaging, and Ma ...
U.S. President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal ...
President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal restrictions ...
The study, conducted at the University Eye Clinic Maastricht, aimed to assess the effectiveness, repeatability, and safety of retreatment in real-world clinical practice using MicroPulse TLT. The ...
U.S. President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal ...
India Today on MSN
Why eye check-up should be integral to preventive healthcare
An eye examination helps detect serious vision conditions like glaucoma early on while also revealing undiagnosed diabetes, ...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for ...
inews.co.uk on MSN
Seven habits that cause eyesight to fail early, according to experts
Here, experts reveal the other causes of failing eyesight, and how to make healthy lifestyle choices to lower your risk ...
Bausch + Lomb's stock remains a "Hold" despite the latest financial results. Here's what investors need to keep in mind.
Being a physician is a privilege because your skills can truly change a life.Restoring sight gives someone back their ...
Researchers found a chasm between the health reasons for which the public seeks out cannabis and what gold-standard science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback